Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-Release (Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate) Drug Interactions

Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.

A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-Release. Always confirm against the full prescribing information.

100 interactions

Abacavir

The risk or severity of liver damage can be increased when Amphetamine is combined with Abacavir.

Level 2 evidence

Abatacept

The metabolism of Amphetamine can be increased when combined with Abatacept.

Level 1 evidence

Abatacept

The metabolism of Dextroamphetamine can be increased when combined with Abatacept.

Level 1 evidence

Abemaciclib

The risk or severity of liver damage can be increased when Amphetamine is combined with Abemaciclib.

Level 2 evidence

Abiraterone

The metabolism of Amphetamine can be decreased when combined with Abiraterone.

Level 1 evidence

Abiraterone

The metabolism of Dextroamphetamine can be decreased when combined with Abiraterone.

Level 1 evidence

Acalabrutinib

The risk or severity of liver damage can be increased when Amphetamine is combined with Acalabrutinib.

Level 2 evidence

Acamprosate

The risk or severity of liver damage can be increased when Amphetamine is combined with Acamprosate.

Level 2 evidence

Acarbose

The risk or severity of liver damage can be increased when Amphetamine is combined with Acarbose.

Level 2 evidence

Aceclofenac

The risk or severity of liver damage can be increased when Amphetamine is combined with Aceclofenac.

Level 2 evidence

Acetaminophen

The risk or severity of liver damage can be increased when Amphetamine is combined with Acetaminophen.

Level 2 evidence

Acetazolamide

Acetazolamide may decrease the excretion rate of Dextroamphetamine which could result in a higher serum level.

Level 1 evidence

Acetazolamide

Acetazolamide may decrease the excretion rate of Amphetamine which could result in a higher serum level.

Level 1 evidence

Enter your NPI to unlock 6 major interactions for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-Release

I don't know my NPI#

More tools for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-Release

Check coverage & formularyVerify PA requirements for your patient's plan.Prior authorization formsDownload PA forms and appeal templates.Find savings programsCopay cards, patient assistance, and more.

Frequently Asked Questions (FAQ)